Researchers recently explored new pharmacological interventions for renal ischemia-reperfusion injury, a leading cause of acute kidney injury (AKI). Since this condition lacks a precise clinical target, the study compared the protective effects of dose-matched glucocorticoids. The team specifically evaluated hydrocortisone and dexamethasone in a rat model to determine which steroid provides better renal protection after blood flow restoration.

Furthermore, the researchers established a 60-minute bilateral model in Sprague Dawley rats. They administered either hydrocortisone (26.7 mg/kg) or dexamethasone (1 mg/kg) intravenously immediately following reperfusion. Consequently, they analyzed blood and kidney tissue 24 hours later to assess dysfunction and histological damage.

Mechanisms of Renal Ischemia-Reperfusion Injury Protection

The results demonstrated that dexamethasone significantly outperformed hydrocortisone. Specifically, dexamethasone successfully lowered serum creatinine levels and reduced injury scores. In contrast, hydrocortisone showed limited efficacy in these areas. Moreover, TUNEL staining confirmed that dexamethasone reduced apoptosis in the kidneys, whereas hydrocortisone had no significant anti-apoptotic effect.

Notably, both steroids attenuated the expression of tumor necrosis factor alpha (TNF-α). However, the dexamethasone group achieved near-baseline levels. Additionally, both treatments restored the expression of the ATPase H transporting V0 subunit D2, which usually declines during injury. Despite these improvements, heme oxygenase-1 expression remained suppressed across all groups.

Selecting the Right Steroid for Clinical Practice

In conclusion, the study highlights that dexamethasone appears more effective than hydrocortisone in mitigating acute kidney damage. These findings suggest that clinicians should consider context-specific steroid selection. While both agents offer some anti-inflammatory benefits, dexamethasone provides superior protection against the cellular death and functional decline associated with ischemia.

Frequently Asked Questions

Why is dexamethasone preferred over hydrocortisone for renal IRI?

Dexamethasone shows greater efficacy in reducing serum creatinine and preventing tubular apoptosis. Unlike hydrocortisone, it significantly lowers histological injury scores in the acute phase of recovery.

Does steroid treatment completely restore kidney function after injury?

While glucocorticoids like dexamethasone improve glomerular filtration and reduce inflammation, they may not restore all biochemical markers. For instance, this study showed that heme oxygenase-1 levels remained suppressed despite treatment.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Professional medical guidance should always be sought for any health-related concerns. Refer to the latest local and national guidelines for clinical practice.

References

Kang M et al. Pharmacological intervention for renal ischemia-reperfusion injury with dose-matched glucocorticoids. Clin Transplant Res. 2026 May 22. doi: 10.4285/ctr.25.0078. PMID: 42168768.

Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev. 2015;4(2):20-27.

Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7(4):189-200.